Skip to main content
. 2019 Jun 20;9:546. doi: 10.3389/fonc.2019.00546

Figure 3.

Figure 3

IL-17A promotes migration of human cancer cells. Confluent monolayer of HeLa and DU-145 cells was scratched to make a wound and then treated without (control group) or with 20 ng/ml recombinant human IL-17A for the indicated time points. (A,C) Representative photomicrographs of the wounds; dotted lines mark the front edges of migrating cells; scale bar, 400 μm. (B,D) Wound healing rate was calculated as (wound width of time zero–that of each time point) ÷ wound width of time zero × 100%; data represent mean ± standard deviation (SD, error bars) of 3 independent experiments; *p < 0.05 between the IL-17A-treated group and the untreated control group.